Related Research Articles
NYU Grossman School of Medicine is a medical school of New York University,a private research university in New York City. It was founded in 1841 and is one of two medical schools of the university,with the other being the Long Island School of Medicine. NYU Grossman School of Medicine is part of NYU Langone Health,named after Kenneth Langone,the investment banker and financial backer of The Home Depot.
Nancy Goodman Brinker is the founder of The Promise Fund and Susan G. Komen for the Cure. Brinker was also United States Ambassador to Hungary from 2001 to 2003 and Chief of Protocol of the United States from 2007 to the end of the George W. Bush administration. In 2011,she was appointed a Goodwill Ambassador for Cancer Control by the World Health Organization. For her work on breast cancer research,Time magazine named Brinker to its 2008 list of the 100 most influential people in the world. Brinker was awarded the Presidential Medal of Freedom by Barack Obama on August 12,2009.
Kathie-Ann Joseph is a surgeon and researcher at New York University Langone Health where she specializes in breast surgery and oncology surgery. Joseph is also the chief of breast surgery at Bellevue Medical Center,where she was recognized in 2015 as Bellevue's Physician of the Year. Joseph works to reduce disparities in cancer care in order to improve health care for individuals in need. Specifically,Joseph focuses on developing programs that will help African-American women to address their needs in breast cancer prevention and care. She is also studying the effects of a cell surface receptor molecule called RAGE which appears to play a role in tumor growth.
David B. Agus is an American physician,cancer researcher and author who serves as a professor of medicine and engineering at the University of Southern California Keck School of Medicine and Viterbi School of Engineering and the Founding Director and CEO of the Lawrence J. Ellison Institute for Transformative Medicine. He is also the cofounder of several personalized medicine companies and a contributor to CBS News on health topics. He is also the author of four books.
Olufunmilayo I. Olopade born in the year 1957,is a Nigerian hematology oncologist,Associate Dean for Global Health and Walter L. Palmer,Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.
High-dose chemotherapy and bone marrow transplant (HDC/BMT),also high-dose chemotherapy with autologous bone marrow transplant,was an ineffective treatment regimen for metastatic breast cancer,and later high-risk breast cancer,that was considered promising during the 1980s and 1990s. With an overall idea that more is better,this process involved taking cells from the person's bone marrow to store in a lab,then to give such high doses of chemotherapy drugs that the remaining bone marrow was destroyed,and then to inject the cells taken earlier back into the body as replacement. It was ultimately determined to be no more effective than normal treatment,and to have significantly higher side effects,including treatment-related death.
Kenneth Offit is an American cancer geneticist and oncologist. He is currently Chief of the Clinical Genetics Service and the Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center. Offit is also a member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute,Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College,and a member of both the Board of Scientific Counselors of the National Cancer Institute and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control.
Eric P. Winer is a medical oncologist and clinical researcher specializing in breast cancer. He is director of Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital Yale New Haven Health System,effective February 1,2022. He also is Deputy Dean for Cancer Research at Yale School of Medicine. From 1997 to 2021,he was the Chief of the Breast Oncology Program at Dana–Farber Cancer Institute in Boston,Massachusetts. Beginning in 2013,he held a range of institutional roles at Dana-Farber,including Chief of Clinical Development,the Thompson Chair in Breast Cancer Research and Director of the Dana-Farber/Harvard SPORE in Breast Cancer. He also served as a Professor of Medicine at Harvard Medical School. He was president of the American Society of Clinical Oncology (ASCO) 2022-2023 and became Chair of the Board in mid-June 2023. His career has been focused on breast cancer treatment and research.
Alan Stuart Coates is an Australian professor of clinical oncology,medical researcher and administrator. He was the inaugural CEO of the Cancer Council Australia (1998–2006),former president of the Clinical Oncological Society of Australia (COSA),and co-chair of the St. Gallen International Breast Cancer Conference. He was also the first non-American to be elected to the board of directors of the American Society of Clinical Oncology.
Richard Margolese,MD,CM FRCS (C),is a Canadian scientist and has been a leader of multiple research studies that have changed the standard treatment for early-stage breast cancer. He is a native of Montreal,Canada.
Sonja Eva Singletary was an American surgeon who specialized in the care of breast cancer. She was a faculty member at the University of Texas MD Anderson Cancer Center and a past president of the Society of Surgical Oncology.
Tatiana Michelle Prowell is an American medical oncologist specializing in breast cancer. She is an Associate Professor of Oncology at Johns Hopkins School of Medicine and Breast Cancer Scientific Liaison at the U.S. Food &Drug Administration.
Ann Hart Partridge is an American medical oncologist. She is the founder and director of the Young and Strong Program for Young Women with Breast Cancer at the Susan F. Smith Center for Women's Cancers at the Dana–Farber Cancer Institute.
Reshma Jagsi is an American Radiation oncologist. She is the Lawrence W. Davis Professor and Chair in the Department of Radiation Oncology and Senior Faculty Fellow in the Center for Ethics at Emory University. Overall,she is the author of over 450 published articles in peer-reviewed medical journals and continues scholarly research in three primary areas of interest:breast cancer,bioethics,and gender equity,with the support of grants from the National Institutes of Health (NIH),the Doris Duke Charitable Foundation,and the Susan G. Komen Foundation,for which she serves as a Senior Scholar.
Folakemi Titilayo Odedina is a Nigerian-born scientist and professor of pharmacy and medicine at the University of Florida. She is the principal investigator for the Prostate Cancer Transatlantic Consortium (CaPTC),a clinical research group using genomic science and environmental etiology to exploring disproportionate burden of prostate cancer among Black men funded by the NCI. She is a member of American Cancer Society's National Prostate Cancer Disparities Advisory Team.
Lori Jo Pierce is an American radiation oncologist and 57th President of the American Society of Clinical Oncology. She is a Full Professor and Vice Provost for Academic and Faculty Affairs at the University of Michigan. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer,with emphasis on intensity modulated radiotherapy in node positive breast cancer,the use of radiosensitizing agents,and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.
Stephanie Lynn Schutt Graff is an American breast medical oncologist. She is the Director of Breast Oncology at the Lifespan Cancer Institute and an Assistant Professor of Medicine at Alpert Medical School. Previously she was the Director of both the Breast Program and Clinical Research at Sarah Cannon Research Institute at HCA Midwest Health at Sarah Cannon Research Institute and Associate Director of the Breast Cancer Research Program at Sarah Cannon Research Institute.
Nancy Lin is an American oncologist who works at the Dana-Farber Cancer Institute and is an Associate Professor of Medicine at Harvard Medical School. Her research considers new diagnostic strategies and treatment pathways for HER2 positive breast cancer.
Kelly A. Metcalfe is a Canadian scientist and a professor at the University of Toronto and at Women's College Hospital. Her work's focus is on understanding the clinical and psychosocial implications of genetic testing for BRCA gene mutations in women,men and their families.
Benjamin G. Neel is an American cancer biologist. He is the Director of the Perlmutter Cancer Center and Professor of Medicine at NYU Langone Health. Neel formally served as the Director of research for Princess Margaret Cancer Centre and a Canada Research Chair at the University of Toronto. He is a member of the National Academy of Sciences and Royal Society of Canada.
References
- ↑ "Meet Dr Ophira Ginsburg, Elsa Atkin Distinguished Fellow". George Institute for Global Health. Retrieved February 13, 2022.
- ↑ "OPHIRA GINSBURG". World Health Organization. Retrieved February 13, 2022.
- 1 2 "Women's College scientist brings breast care to Bangladesh with Grand Challenges Canada's Rising Stars in Global Health award" (PDF). Women's College Hospital. February 9, 2012. Retrieved February 13, 2022.
- ↑ Skinner, Justin (February 25, 2012). "Innovative breast cancer program exported to Bangladesh". toronto.com. Retrieved February 13, 2022.
- ↑ "Women's College Hospital clinician-scientist to receive prestigious YWCA award" (PDF). Women's College Hospital. March 12, 2013. Retrieved February 13, 2022.
- ↑ Ubelacker, Sheryl (August 17, 2015). "Canadian doctor to help guide women's cancer care in developing world". CTV News. Retrieved February 13, 2022.
- ↑ "300 WOMEN LEADERS IN GLOBAL HEALTH" (PDF). Graduate Institute of International and Development Studies . Retrieved February 13, 2022.
- ↑ "South Asian women more likely to be diagnosed with later stage breast cancer". Women's College Hospital. July 2015. Retrieved February 13, 2022.
- ↑ "Ophira Ginsburg, MD, to Lead New High Risk Program at NYU Langone's Perlmutter Cancer Center". The ASCO Post. April 25, 2017. Retrieved February 13, 2022.
- ↑ "Dr Ophira Ginsburg announced as Elsa Atkin Distinguished Fellow". George Institute for Global Health. August 27, 2020. Retrieved February 13, 2022.
- ↑ Ginsburg, Ophira; Basu, Partha; Kapambwe, Sharon; Canfell, Karen (February 2021). "Eliminating cervical cancer in the COVID-19 era" (PDF). Nature Cancer. 2 (2): 133–134. doi:10.1038/S43018-021-00178-9. ISSN 2662-1347. Wikidata Q111610848 . Retrieved February 13, 2022.
- ↑ "ASCO Honors 2022 Special Awards Recipients". ASCO Connection. 2022-03-29. Retrieved 2022-05-12.
- ↑ "100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023". OncoDaily.
